Introduction Coronavirus disease of 2019 (COVID-19) has resulted in millions of cases
worldwide. As the pandemic has progressed, the understanding of this disease has evolved …

Vaccines and monoclonal antibody treatments to prevent severe coronavirus disease 2019
(COVID-19) illness were available within a year of the pandemic being declared but there …

This guideline is based on the above strategic priorities, and is intended for clinicians
involved in the care of patients with suspected or confirmed COVID-19. It is not meant to …

Background The proportion of patients infected with SARS-CoV-2 that are prescribed
antibiotics is uncertain, and may contribute to patient harm and global antibiotic resistance …

Purpose: COVID-19-associated rhino-orbital-cerebral mucormycosis (ROCM) has reached
epidemic proportion during India's second wave of COVID-19 pandemic, with several risk …

ObjectiveTo study the possible association between invasive fungal sinusitis
(mucormycosis) and coronavirus disease. MethodsA prospective observational study was …

The guidance in this document is based on the above strategic priorities, and is intended for
clinicians involved in the care of patients with suspected or confirmed COVID-19. It is not …

In addition to SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection
itself, an increase in the incidence of antimicrobial resistance poses collateral damage to the …

Introduction The recovery of other pathogens in patients with SARS-CoV-2 infection has
been reported, either at the time of a SARS-CoV-2 infection diagnosis (co-infection) or …

Background Few small studies have described hospital-acquired infections (HAIs) occurring
in patients with COVID-19. Research Question What characteristics in critically ill patients …